Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=701c1345-9d10-4714-a71c-85b64d84d582
Date 10/16/2014
Company Name Tetra Discovery Partners
Mailing Address 301 Michigan Street NE Grand Rapids, MI 49503 USA
Company Description Our research focuses on developing new treatments for depression based on subtype-selective modulation of phosphodiesterase 4B (PDE4B). PDE4 in neurons is responsible for the hydrolysis of cAMP. We and our colleagues recently described the protein structure of a key PDE4 regulatory domain known as UCR2.
Proceeds Purposes The company intends to use the funds to support additional work aimed at the filing of its first Investigational New Drug (IND) application for cognition drug candidate in 2015.